Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Almejally A"'
Autor:
Bunyan, Reem F., AlAbdulSalam, Abdulaziz M., Albarakati, Rayan G., Al Harbi, Awad A., Alissa, Dema A., Al-Jedai, Ahmed H., AlKhawajah, Nuha M., Al Malik, Yaser M., Almejally, Mousa A., Al-Mudaiheem, Hajer Y., AlNajashi, Hind A., AlShehri, Amani A., Althubaiti, Ibtisam A., AlYafeai, Rumaiza H., Babakkor, Mohammed A., Cupler, Edward J., Ka, Mamdouh H., Saeedi, Jameelah A., Shosha, Eslam, Al Jumah, Mohammed A.
Publikováno v:
In Multiple Sclerosis and Related Disorders October 2022 66
Autor:
Ibtisam A. Al Thubaiti, Mona M. AlKhawajah, Norah Al Fugham, Dema A. Alissa, Ahmed H. Al-Jedai, Yaser M. Al Malik, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Bedor A. Al-Omari, Hessa S. AlOtaibi, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Hanaa M. Kedah, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammed A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 7, Iss 1, p 6 (2023)
This article deals with recommendations on the management of symptoms of MS and on the provision of vaccinations in patients receiving disease-modifying therapies (DMTs). Symptoms of MS, such as fatigue, depression, urinary symptoms, spasticity, impa
Externí odkaz:
https://doaj.org/article/2183e4d78c6e4b98b414b3349982ffa1
Autor:
Yaser M. Al Malik, Ibtisam A. Al Thubaiti, Maha A. AlAmmari, Norah Al Fugham, Eman N. Ali, Dema A. Alissa, Salman A. Aljarallah, Ahmed H. Al-Jedai, Maeed A. AlKathiri, Mona M. AlKhawajah, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Hessa S. Al Otaibi, Ghadah H. AlTowaijri, Rumaiza H. Al Yafeai, Mohammed A. Babakkor, Saeed A. Bohlega, Reem F. Bunyan, Edward J. Cupler, Mohammed Hakami, Abid M. Kareem, Amr M. Khardaly, Seraj Makkawi, Leena H. Saeed, Jameelah A. Saeedi, Eslam Shosha, Mohammad A. Al Jumah
Publikováno v:
Clinical and Translational Neuroscience, Vol 6, Iss 4, p 27 (2022)
For the past 10 years, disease-modifying therapy (DMT) options for multiple sclerosis (MS) have grown remarkably where DMTs have been shown to reduce the risk of MS relapses. MS patients are advised to begin treatment with a DMT shortly after diagnos
Externí odkaz:
https://doaj.org/article/2fb7ce205ae64e98a94d6195cedec570
Autor:
Reem F. Bunyan, Abdulaziz M. AlAbdulSalam, Rayan G. Albarakati, Awad A. Al Harbi, Dema A. Alissa, Ahmed H. Al-Jedai, Nuha M. AlKhawajah, Yaser M. Al Malik, Mousa A. Almejally, Hajer Y. Al-Mudaiheem, Hind A. AlNajashi, Amani A. AlShehri, Ibtisam A. Althubaiti, Rumaiza H. AlYafeai, Mohammed A. Babakkor, Edward J. Cupler, Mamdouh H. Ka, Jameelah A. Saeedi, Eslam Shosha, Mohammed A. Al Jumah
Publikováno v:
Multiple sclerosis and related disorders. 66
Multiple sclerosis (MS) most commonly presents in young adults, although 3-5% of patients develop MS prior to the age of 18 years. The new and comprehensive consensus for the management of MS in Saudi Arabia includes recommendations for the managemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2687077e799d1d91097bb7a7634cb711
https://pubmed.ncbi.nlm.nih.gov/35908447
https://pubmed.ncbi.nlm.nih.gov/35908447
Autor:
Al Thubaiti, Ibtisam A., AlKhawajah, Mona M., Al Fugham, Norah, Alissa, Dema A., Al-Jedai, Ahmed H., Al Malik, Yaser M., Almejally, Mousa A., Al-Mudaiheem, Hajer Y., Al-Omari, Bedor A., AlOtaibi, Hessa S., Al Yafeai, Rumaiza H., Babakkor, Mohammed A., Bunyan, Reem F., Cupler, Edward J., Hakami, Mohammed, Kedah, Hanaa M., Makkawi, Seraj, Saeed, Leena H., Saeedi, Jameelah A., Shosha, Eslam
Publikováno v:
Clinical & Translational Neuroscience; Mar2023, Vol. 7 Issue 1, p1-16, 16p
Autor:
Al Malik, Yaser M., Al Thubaiti, Ibtisam A., AlAmmari, Maha A., Fugham, Norah Al, Ali, Eman N., Alissa, Dema A., Aljarallah, Salman A., Al-Jedai, Ahmed H., AlKathiri, Maeed A., AlKhawajah, Mona M., Almejally, Mousa A., Al-Mudaiheem, Hajer Y., Al Otaibi, Hessa S., AlTowaijri, Ghadah H., Al Yafeai, Rumaiza H., Babakkor, Mohammed A., Bohlega, Saeed A., Bunyan, Reem F., Cupler, Edward J., Hakami, Mohammed
Publikováno v:
Clinical & Translational Neuroscience; Dec2022, Vol. 6 Issue 4, p1-17, 17p
Publikováno v:
In Journal of the Neurological Sciences October 2021 429 Supplement
Autor:
Abdulla Alamri, Salman Aljarallah, Mohammad Almuaigel, Nuha M. Alkhawajah, Hind Alnajashi, Jameelah Saeedi, Yaser Almalik, Seraj Makkawi, Foziah Alshamrani, Mousa Almejally, Hessa Alotaibi, Sadiq Alsalman, Shireen Qureshi, Mohammed Aljumah, Hanaa Kedah
Publikováno v:
Multiple Sclerosis and Related Disorders
Background The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread and developed as a pandemic threatening global health. Patients with multiple sclerosis (MS)–an autoimmune demyelinating inflammatory disease of the central nervous s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba23672929aecbbb9bab9f0e03f2376b
http://europepmc.org/articles/PMC8103739
http://europepmc.org/articles/PMC8103739
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.